US Bancorp’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $164K | Sell |
|
|||||
|
2025
Q1 | $166K | Buy |
|
|||||
|
2024
Q4 | $224K | Buy |
|
|||||
|
2024
Q3 | $174K | Sell |
|
|||||
|
2024
Q2 | $374K | Buy |
|
|||||
|
2024
Q1 | $116K | Buy |
|
|||||
|
2023
Q4 | $40K | Buy |
|
|||||
|
2023
Q3 | $28.6K | Buy |
|
|||||
|
2023
Q2 | $13.7K | Sell |
|
|||||
|
2023
Q1 | $89.6K | Sell |
|
|||||
|
2022
Q4 | $96.2K | Sell |
|
|||||
|
2022
Q3 | $87K | Buy |
|
|||||
|
2022
Q2 | $77K | Sell |
|
|||||
|
2022
Q1 | $106K | Sell |
|
|||||
|
2021
Q4 | $94K | Buy |
|
|||||
|
2021
Q3 | $112K | Sell |
|
|||||
|
2021
Q2 | $124K | Sell |
|
|||||
|
2021
Q1 | $167K | Sell |
|
|||||
|
2020
Q4 | $155K | Sell |
|
|||||
|
2020
Q3 | $146K | Sell |
|
|||||
|
2020
Q2 | $234K | Sell |
|
|||||
|
2020
Q1 | $175K | Buy |
|
|||||
|
2019
Q4 | $115K | Sell |
|
|||||
|
2019
Q3 | $99K | Sell |
|
|||||
|
2019
Q2 | $248K | Sell |
|
|||||
|
2019
Q1 | $705K | Sell |
|
|||||
|
2018
Q4 | $1.91M | Sell |
|
|||||
|
2018
Q3 | $3.57M | Buy |
|
|||||
|
2018
Q2 | $3.61M | Buy |
|
|||||
|
2018
Q1 | $818K | Sell |
|
|||||
|
2017
Q4 | $968K | Sell |
|
|||||
|
2017
Q3 | $1.43M | Sell |
|
|||||
|
2017
Q2 | $3.28M | Sell |
|
|||||
|
2017
Q1 | $3.54M | Sell |
|
|||||
|
2016
Q4 | $4.63M | Sell |
|
|||||
|
2016
Q3 | $10.2M | Sell |
|
|||||
|
2016
Q2 | $14.3M | Sell |
|
|||||
|
2016
Q1 | $19.2M | Sell |
|
|||||
|
2015
Q4 | $25.4M | Sell |
|
|||||
|
2015
Q3 | $23.3M | Sell |
|
|||||
|
2015
Q2 | $26.9M | Buy |
|
|||||
|
2015
Q1 | $27.3M | Buy |
|
|||||
|
2014
Q4 | $25.1M | Buy |
|
|||||
|
2014
Q3 | $22.4M | Buy |
|
|||||
|
2014
Q2 | $19.6M | Buy |
|
|||||
|
2014
Q1 | $15.2M | Buy |
|
|||||
|
2013
Q4 | $10.3M | Sell |
|
|||||
|
2013
Q3 | $10.9M | Sell |
|
|||||
|
2013
Q2 | $11.8M | Buy |
|